Literature DB >> 17097854

Transcultural differences in suicide attempters: analysis on a high-risk population of patients with schizophrenia or schizoaffective disorder.

A C Altamura1, E Mundo, R Bassetti, A Green, J P Lindenmayer, L Alphs, H Y Meltzer.   

Abstract

The aim of the study was to investigate transcultural differences between schizophrenia spectrum disorder patients who did or did not attempt suicide. DSM-IV schizophrenia (N=609) or schizoaffective disorder (N=371) patients who participated in the multicentre International Suicide Prevention Trial (InterSePT) were studied. Patients were sub-divided into 5 groups according to the different geographical regions of recruitment: North America (NA), Europe (EUR), East Europe (EEUR), South Africa (SAf), and South America (SA). The main lifetime clinical variables were compared, within each group, between attempters and non-attempters. The presence of comorbid substance abuse disorder and smoking was associated with suicide attempts in all the geographical groups considered (NA: chi(1)(2)=7.575, p<0.01 and chi(1)(2)=69.549, p<0.0001; EUR: chi(1)(2)=55.068, p<0.0001, and chi(1)(2)=48.431, p<0.0001; EEUR: chi(1)(2)=164.628, p<0.000, and chi(1)(2)=5.127, p<0.01; SA: chi(1)(2)=30.204, p<0.0001 and chi(1)(2)=11.710, p=0.001) except for SAf. For the other clinical variables various differences were found across the different groups. Variables related to suicide behavior were similar across the five groups investigated, with differences only in the age at the first suicide attempt (earlier in the NA sample) and the number of lifetime suicide attempts (higher in the NA sample). Results from this study show that, while some suicide-related clinical characteristics in schizophrenia patients are consistent worldwide suggesting the influence of stable biological traits, other variables may vary across different geographical areas suggesting environmental influences.

Entities:  

Mesh:

Year:  2006        PMID: 17097854     DOI: 10.1016/j.schres.2006.08.023

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  6 in total

1.  Psychosocial factors contributing to suicidal ideation in hospitalized schizophrenia patients in Korea.

Authors:  Sung-Wan Kim; Su-Jung Kim; Ji-Woong Mun; Kyung-Yeol Bae; Jae-Min Kim; Seon-Young Kim; Su-Jin Yang; Il-Seon Shin; Jin-Sang Yoon
Journal:  Psychiatry Investig       Date:  2010-05-04       Impact factor: 2.505

Review 2.  Suicide and schizophrenia: a systematic review of rates and risk factors.

Authors:  Kahyee Hor; Mark Taylor
Journal:  J Psychopharmacol       Date:  2010-11       Impact factor: 4.153

3.  Smoking, Suicidality and Psychosis: A Systematic Meta-Analysis.

Authors:  Anoop Sankaranarayanan; Serafino Mancuso; Helen Wilding; Suhaila Ghuloum; David Castle
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

Review 4.  A critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorder.

Authors:  Pierre Chue; James Chue
Journal:  Ther Clin Risk Manag       Date:  2016-01-27       Impact factor: 2.423

5.  A cross-sectional study of substance use in patients with schizophrenia hospitalized for relapse at the Ar-Razi Psychiatric Hospital in Salé, CHU Ibn Sina Rabat, Morocco.

Authors:  Aboubacar Abderemane; Taher Moussa Ahmadou; Abderrazzak Khadmaoui; Siham Belbachir; Khalid Barkat; Ahmed Omar Touhami Ahami
Journal:  Pan Afr Med J       Date:  2022-02-08

6.  Substance use and suicidal ideation and behaviour in low- and middle-income countries: a systematic review.

Authors:  Elsie Breet; Daniel Goldstone; Jason Bantjes
Journal:  BMC Public Health       Date:  2018-04-24       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.